Stille AB: Interim Report Q3 2024
Stille AB (publ) today presents the report for the third quarter 2024.
Revenue amounted to MSEK 127.9 (70.1) driven by strong organic growth in surgical instruments and the successful acquisition of Fehling. Total growth amounted to 82.4 percent, of which 7.4 percent was organic growth.
“Organic growth remained robust, despite high comparable figures and slightly lower demand in the surgical table business compared with the same quarter previous year.”, says Torbjörn Sköld and comments on the company’s revised financial targets “Our revised targets reflect our ambition to constantly improve, challenge ourselves and continue evolving.”.
The gross profit margin amounted to 51.8 percent (46.7) and operating profit before non-recurring items amounted to MSEK 23.4 (11.9).
”2024 has continued on a high note – our products are delivering value to our customers, which is creating favorable demand, strong growth and a healthy cash flow.”, concludes Stille’s CEO.
| MSEK | JUL-SEP 2024 | JUL-SEP 2023 | JAN-SEP 2024 | JAN-SEP 2023 | OCT-SEP 2023/24 | JAN-DEC 2023 |
| Net sales | 127.9 | 70.1 | 410.2 | 217.6 | 487.4 | 294.9 |
| Gross profit, % | 51.8 | 46.7 | 49.8 | 44.6 | 50.1 | 44.8 |
| EBITDA before non-recurring items | 30.2 | 15.5 | 99.9 | 45.0 | 117.5 | 62.6 |
| EBITDA before non-recurring items, % | 23.6 | 22.1 | 24.3 | 20.7 | 24.1 | 21.2 |
| EBITDA | 30.2 | 15.5 | 79.8 | 41.7 | 97.5 | 59.3 |
| EBITDA, % | 23.6 | 22.1 | 19.5 | 19.1 | 20.4 | 20.1 |
| Operating profit before non-recurring items | 23.4 | 11.9 | 79.4 | 34.3 | 93.4 | 48.3 |
| Operating profit before non-recurring items, % | 18.3 | 17.0 | 19.4 | 15.8 | 20.0 | 16.4 |
| Operating profit | 23.4 | 11.9 | 59.4 | 31.0 | 73.3 | 45.0 |
| Operating profit, % | 18.3 | 17.0 | 14.5 | 14.2 | 15.5 | 15.2 |
Torshälla, October 24th, 2024.